Inhibikase Therapeutics 将来の成長
Future 基準チェック /06
Inhibikase Therapeutics is forecast to grow earnings and revenue by 29.1% and 91.1% per annum respectively while EPS is expected to grow by 74.7% per annum.
主要情報
29.1%
収益成長率
74.7%
EPS成長率
| Biotechs 収益成長 | 27.1% |
| 収益成長率 | 91.1% |
| 将来の株主資本利益率 | n/a |
| アナリストカバレッジ | Low |
| 最終更新日 | 22 Oct 2024 |
今後の成長に関する最新情報
Recent updates
Can Inhibikase Therapeutics (NASDAQ:IKT) Afford To Invest In Growth?
Jan 25
Inhibikase stock rises 12% on FDA nod to start study of IkT-001Pro for leukemia
Aug 26Inhibikase Therapeutics GAAP EPS of -$0.18, revenue of $6.55M
Aug 12Will Inhibikase Therapeutics (NASDAQ:IKT) Spend Its Cash Wisely?
Aug 09Here's Why We're Watching Inhibikase Therapeutics' (NASDAQ:IKT) Cash Burn Situation
Apr 06業績と収益の成長予測
| 日付 | 収益 | 収益 | フリー・キャッシュフロー | 営業活動によるキャッシュ | 平均アナリスト数 |
|---|---|---|---|---|---|
| 12/31/2026 | N/A | -31 | N/A | -20 | 2 |
| 12/31/2025 | N/A | -24 | N/A | -14 | 2 |
| 12/31/2024 | N/A | -20 | N/A | -18 | 2 |
| 6/30/2024 | 0 | -18 | -16 | -16 | N/A |
| 3/31/2024 | 0 | -19 | -16 | -16 | N/A |
| 12/31/2023 | 0 | -19 | -18 | -18 | N/A |
| 9/30/2023 | 0 | -19 | -18 | -18 | N/A |
| 6/30/2023 | 0 | -19 | -20 | -20 | N/A |
| 3/31/2023 | 0 | -18 | -20 | -19 | N/A |
| 12/31/2022 | 0 | -18 | -18 | -17 | N/A |
| 9/30/2022 | 0 | -19 | -18 | -18 | N/A |
| 6/30/2022 | 0 | -19 | -14 | -14 | N/A |
| 3/31/2022 | 2 | -17 | -14 | -14 | N/A |
| 12/31/2021 | 3 | -15 | -14 | -14 | N/A |
| 9/30/2021 | 3 | -11 | -11 | -11 | N/A |
| 6/30/2021 | 3 | -7 | -9 | -9 | N/A |
| 3/31/2021 | 2 | -5 | -5 | -5 | N/A |
| 12/31/2020 | 1 | -3 | -1 | -1 | N/A |
| 9/30/2020 | 1 | -2 | 0 | 0 | N/A |
| 6/30/2020 | 1 | -3 | 0 | 0 | N/A |
| 3/31/2020 | 1 | -5 | 0 | 0 | N/A |
| 12/31/2019 | 1 | -6 | 0 | 0 | N/A |
| 9/30/2019 | 2 | -7 | 1 | 1 | N/A |
| 3/31/2019 | 4 | -4 | 0 | 0 | N/A |
| 12/31/2018 | 4 | -2 | 1 | 1 | N/A |
| 9/30/2018 | 3 | -1 | 0 | 0 | N/A |
| 3/31/2018 | 3 | 0 | N/A | 0 | N/A |
| 12/31/2017 | 2 | 0 | N/A | 0 | N/A |
| 12/31/2016 | 1 | -1 | N/A | 0 | N/A |
アナリストによる今後の成長予測
収入対貯蓄率: IKT is forecast to remain unprofitable over the next 3 years.
収益対市場: IKT is forecast to remain unprofitable over the next 3 years.
高成長収益: IKT is forecast to remain unprofitable over the next 3 years.
収益対市場: IKT is forecast to have no revenue next year.
高い収益成長: IKT is forecast to have no revenue next year.
一株当たり利益成長率予想
将来の株主資本利益率
将来のROE: Insufficient data to determine if IKT's Return on Equity is forecast to be high in 3 years time